Research Article | OPEN ACCESS
Actinidia arguta Polysaccharide Induces Apoptosis in Hep G2 Cells
1, 2Xueli Yu, 1Changjiang Liu, 2Ying Liu, 1Changhua Tan and 1Yangyang Liu
1College of Food Science, Shenyang Agriculture University, Shenyang 110866, China
2Department of Toxicological Pathology, National Safety and Evaluation Centre of New Drug, Shenyang Research Institute of Chemical Industry, Shenyang 110021, China
Advance Journal of Food Science and Technology 2015 11:857-863
Received: October 29, 2014 | Accepted: December 18, 2014 | Published: April 10, 2015
Abstract
In our previous study, a potential Antitumor Polysaccharide (AAP-3b) was extracted from the fruit of Actinidia arguta. Several earlier studies have indicated that AAP-3b exhibits antioxidant activity. This study was designed to determine the effect of AAP-3b on cytotoxicity in human hepatoma cell line, Hep G2 cells. Hep G2 cells were cultured in the presence of AAP-3b at various concentrations (0.005-1 mg/mL) from 24 to 96 h and the percentage of cell viability was evaluated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl Tetrazolium bromide (MTT) assay. The results showed that AAP-3b inhibited the cells viability in concentration and time dependent characteristics at concentrations (0.05-0.5 mg/mL) from 24 to 72 h. The IC50 (50% cell growth inhibitory concentration) of tumor cell proliferation inhibition from 24 to 72 h were 0.193 (95% confidence interval 0.159 to 0.234), 0.114 (95% confidence interval 0.073 to 0.170), 0.076 (95% confidence interval 0.034 to 0.137) mg/mL respectively. We found that anti-proliferative effect of AAP-3b was associated with cell cycle blocked and apoptosis on Hep G2 cells by determinations of morphological changes, cell cycle and apoptosis. These results provide new insight into the health functions of Actinidia arguta polysaccharide.
Keywords:
AAP-3b, Actinidia arguta, antitumor, Hep G2 cells, polysaccharide,
Competing interests
The authors have no competing interests.
Open Access Policy
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Copyright
The authors have no competing interests.
|
|
|
ISSN (Online): 2042-4876
ISSN (Print): 2042-4868 |
|
Information |
|
|
|
Sales & Services |
|
|
|